“…cannabinoids are emerging novel agents for the treatment of glaucoma.
Although increased intraocular pressure (IOP) is a risk factor, associated retinal damage is of prime concern. This study determines the ability of cannabinoids to decrease IOP and confer neuroprotection…
Conclusion: Topically applied cannabinoids are effective agents that reduce IOP and confer neuroprotection and are prime candidates for potential glaucoma treatment.”
http://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2014.T022.x/abstract